Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Metrics to compare | AIFF | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipAIFFPeersSector | |
---|---|---|---|---|
P/E Ratio | −4.5x | −4.7x | −0.5x | |
PEG Ratio | −0.07 | 0.03 | 0.00 | |
Price/Book | 12.6x | 0.0x | 2.6x | |
Price / LTM Sales | 474.5x | 1.8x | 3.0x | |
Upside (Analyst Target) | - | 71.8% | 54.7% | |
Fair Value Upside | Unlock | 38.0% | 9.3% | Unlock |